Protective and recuperative effects of 3-bromopyruvate on immunological, hepatic and renal homeostasis in a murine host bearing ascitic lymphoma: Implication of niche dependent differential roles of macrophages

Biomed Pharmacother. 2018 Mar:99:970-985. doi: 10.1016/j.biopha.2018.01.149. Epub 2018 Feb 20.

Abstract

3-bromopyruvate (3-BP) possesses promising antineoplastic potential, however, its effects on immunological homeostasis vis a vis hepatic and renal functions in a tumor bearing host remain unclear. Therefore, the effect of 3-BP administration to a murine host bearing a progressively growing tumor of thymoma origin, designated as Dalton's lymphoma (DL), on immunological, renal and hepatic homeostasis was investigated. Administration of 3-BP (4 mg/kg) to the tumor bearing host reversed tumor growth associated thymic atrophy and splenomegaly, accompanied by altered cell survival and repertoire of splenic, bone marrow and tumor associated macrophages (TAM). TAM displayed augmented phagocytic, tumoricidal activities and production of IL-1 and TNF-α. 3-BP-induced activation of TAM was of indirect nature, mediated by IFN-γ. Blood count of T lymphocytes (CD4+ & CD8+) and NK cells showed a rise in 3-BP administered tumor bearing mice. Moreover, 3-BP administration triggered modulation of immunomodulatory cytokines in serum along with refurbished hepatic and renal functions. The study indicates the role of altered cytokines balance, site specific differential macrophage functions and myelopoiesis in restoration of lymphoid organ homeostasis in 3-BP administered tumor bearing host. These observations will have long lasting impact in understanding of alternate mechanisms underlying the antitumor action of 3-BP accompanying appraisal of safety issues for optimizing its antineoplastic actions.

Keywords: 3-Bromopyruvate; Macrophages; Organ functions; Splenomegaly; Thymic atrophy; Thymoma.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Ascites / blood
  • Ascites / drug therapy*
  • Ascites / pathology
  • Ascitic Fluid / metabolism
  • Atrophy
  • Cell Count
  • Cytokines / blood
  • Homeostasis / drug effects*
  • Interferon-gamma / metabolism
  • Kidney / drug effects
  • Kidney / immunology*
  • Kidney / pathology
  • Kidney / physiopathology
  • Liver / drug effects
  • Liver / immunology*
  • Liver / pathology
  • Liver / physiopathology
  • Lymphoma / blood
  • Lymphoma / drug therapy*
  • Lymphoma / immunology
  • Lymphoma / pathology
  • Macrophages / drug effects
  • Macrophages / pathology*
  • Mice, Inbred BALB C
  • Protective Agents / pharmacology
  • Protective Agents / therapeutic use*
  • Pyruvates / administration & dosage
  • Pyruvates / pharmacology
  • Pyruvates / therapeutic use*
  • Receptors, Interleukin-2 / metabolism
  • Spleen / drug effects
  • Spleen / pathology
  • Thymocytes / drug effects
  • Thymocytes / pathology
  • Thymus Gland / drug effects
  • Thymus Gland / pathology

Substances

  • Cytokines
  • Protective Agents
  • Pyruvates
  • Receptors, Interleukin-2
  • bromopyruvate
  • Interferon-gamma